Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen: Waiting for Clarity on Generic Biotech
Barron's
Fri, 08/21/15 - 11:05 am
Tags:
Amgen, generics, biosimilars, Novartis, Sandoz, Neupogen, Zarxio
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Bidness, ETC
Wed, 08/19/15 - 09:28 am
Tags:
Amgen, romosozumab, osteoporosis
Amgen, U.S. states in $71 mln settlement over drug marketing
Yahoo/Reuters
Tue, 08/18/15 - 01:25 pm
Tags:
Amgen, off-label, Aranesp, Enbrel
You’re Better Than My Last Dance Partner But Still Not Perfect: Amgen Alleges that an Otherwise Complete Patent Dance Was Ruined by Pre-Approval Notice of Marketing
FDA Law Blog
Mon, 08/17/15 - 08:13 am
Tags:
FDA, Amgen, Neulasta, Apotex, biogenerics, patents
AbbVie And Amgen Threatened By Biosimilars
Bidness, ETC
Mon, 08/17/15 - 07:57 am
Tags:
AbbVie, Amgen, biosimilars, JNJ, Sandoz, Novartis, Humira, Neupogen, Remicade, Nuelasta, Enbrel, epoetin-alfa
Payers Set To Play Hardball On PCSK9 Pricing
Investors.com
Fri, 08/14/15 - 11:22 am
Tags:
payer negotiation, drug pricing, PCSK9 inhibitors, Sanofi, Regeneron, Amgen, hepatitis C, Express Scripts
Journalist fights Amgen subpoena in Aranesp class action suit
Fierce Pharma
Thu, 08/13/15 - 02:42 pm
Tags:
Amgen, journalists, subpoena, Aranesp
Amgen: What If Generic Neulasta Gets Delayed Until Next Year?
Barron's
Wed, 08/12/15 - 12:49 pm
Tags:
Neulasta, generics, Amgen, Apex Labs, biosimilars
CVS to adopt 'wait and see' approach on PCSK9 cholesterol meds
BioPharma Dive
Mon, 08/10/15 - 10:53 am
Tags:
CVS, PCSK9 inhibitors, formulary, Sanofi, Regeneron, Praluent, Amgen, Repatha
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
Tags:
FDA, Exelixis, vemurafenib, aripiprazole lauroxil, Alkermes, evolocumab, Amgen, Bristol-Myers Squibb, Opdivo, Clovis Oncology, rociletinib
Dr. Reddy’s Announces Strategic Collaboration with Amgen in India
Yahoo
Thu, 08/6/15 - 10:21 am
Tags:
Dr Reddy's, Amgen, India, Kyprolis, Blincyto, Repatha
A Post-Earnings Review Of Amgen, With Discussion Of The Repatha Launch
Seeking Alpha
Mon, 08/3/15 - 12:14 pm
Tags:
Amgen, earnings, Repatha, drug launches
Amgen, Alexion Top Views, But Their Outlooks Differ
Yahoo/Investors.com
Sun, 08/2/15 - 11:18 am
Tags:
Amgen, Alexion, earnings
CEO Bradway, and markets, like the way Amgen's 'new product story' is shaping up
Fierce Biotech
Fri, 07/31/15 - 03:35 pm
Tags:
Amgen, Bob Bradway
Amgen lops another 10% off its R&D budget amid wide cost cuts
Fierce Biotech
Fri, 07/31/15 - 03:29 pm
Tags:
Amgen, R&D
Amgen profit tops Street view, boosts full-year forecast
Yahoo/Reuters
Thu, 07/30/15 - 05:25 pm
Tags:
Amgen, earnings
Amgen, Inc. (AMGN) Q2 Earnings: What To Expect
Bidness, ETC
Wed, 07/29/15 - 10:37 am
Tags:
Amgen, earnings
Wait, Will Allergan Really Buy Biogen or Amgen?
Barron's
Tue, 07/28/15 - 11:57 am
Tags:
Allergan, Biogen, Amgen, M&A
Sanofi draws a $14,600 line in the sand for Praluent payer fight
Fierce Pharma Marketing
Tue, 07/28/15 - 10:22 am
Tags:
Sanofi, Praluent, Repatha, Amgen, Regeneron, drug pricing, PCSK9 inhibitors
3 Questions to Ask Ahead of Amgen's Second-Quarter Earnings Release
Motley Fool
Tue, 07/28/15 - 12:33 am
Tags:
Amgen, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.